Advisory Research’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,613
Closed -$858K 158
2023
Q4
$858K Sell
6,613
-11,149
-63% -$1.54M 0.13% 179
2023
Q3
$2.9M Buy
17,762
+924
+5% +$163K 0.4% 65
2023
Q2
$3.09M Buy
16,838
+15,084
+860% +$2.17M 0.4% 64
2023
Q1
$234K Buy
+1,754
New +$206K 0.04% 317

Other funds holding ACLS

Advisory Research's ACLS Position: Q1 2024 in Review

Advisory Research sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 6,613 shares — an estimated $858K sold.

Advisory Research first reported a position in ACLS in Q1 2023 and held it in 4 quarters. The position peaked at $3.09M in Q2 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Advisory Research reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • Advisory Research sold 6,613 Axcelis shares in Q1 2024, an estimated $858K.
  • Advisory Research first reported a position in Axcelis in Q1 2023 and held it in 4 quarters.
  • Advisory Research's Axcelis position peaked at $3.09M in Q2 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.